Thomson Medical Group
Market Cap
S$1.5b
Last Updated
2019/10/14 12:55 UTC
Data Sources
Company Financials
Executive Summary
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally.
Snowflake
Fundamentals
Moderate growth potential with weak fundamentals.
Similar Companies
Share Price & News
How has Thomson Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
3.5%
A50
0.9%
SG Healthcare
0.9%
SG Market
1 Year Return
-28.0%
A50
-11.4%
SG Healthcare
1.4%
SG Market
Return vs Industry: A50 underperformed the SG Healthcare industry which returned -11.4% over the past year.
Return vs Market: A50 underperformed the SG Market which returned 1.4% over the past year.
Shareholder returns
| A50 | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.5% | 0.9% | 0.9% |
| 30 Day | -3.3% | 0.8% | -2.3% |
| 90 Day | -9.2% | -4.3% | -6.7% |
| 1 Year | -27.8%-28.0% | -9.9%-11.4% | 5.4%1.4% |
| 3 Year | n/a | -20.1%-25.0% | 15.8%3.4% |
| 5 Year | n/a | -14.7%-23.6% | 11.3%-7.0% |
Price Volatility Vs. Market
How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt1 month ago | Simply Wall St
Did You Manage To Avoid Thomson Medical Group's (SGX:A50) 25% Share Price Drop?2 months ago | Simply Wall St
Thomson Medical Group Limited (SGX:A50) Might Not Be A Great InvestmentValuation
Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?
211.47x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: A50 (SGD0.06) is trading above our estimate of fair value (SGD0.02)
Significantly Undervalued: A50 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A50 is poor value based on its PE Ratio (211.5x) compared to the Healthcare industry average (27.1x).
PE vs Market: A50 is poor value based on its PE Ratio (211.5x) compared to the SG market (13.4x).
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate A50's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A50 is overvalued based on its PB Ratio (2.7x) compared to the SG Healthcare industry average (2.3x).
Next Steps
Future Growth
How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
32.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A50's forecast earnings growth (32.6% per year) is above the savings rate (2.3%).
Earnings vs Market: A50's earnings (32.6% per year) are forecast to grow faster than the SG market (5.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A50's revenue is forecast to grow faster than the SG market.
High Growth Revenue: Insufficient data to determine if A50's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if A50's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Thomson Medical Group performed over the past 5 years?
-34.7%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: A50's earnings have declined by -34.7% per year over the past 5 years.
Accelerating Growth: A50's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A50 had negative earnings growth (-46.8%) over the past year, making it difficult to compare to the Healthcare industry average (-13.3%).
Return on Equity
High ROE: A50's Return on Equity (1.8%) is considered low.
Return on Assets
ROA vs Industry: A50's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: A50's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is Thomson Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: A50's short term assets (SGD292.3M) do not cover its short term liabilities (SGD298.0M)
Long Term Liabilities: A50's short term assets (292.3M) do not cover its long term liabilities (360.9M)
Debt to Equity History and Analysis
Debt Level: A50's debt to equity ratio (87.5%) is considered high
Reducing Debt: Insufficient data to determine if A50's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A50's debt is not well covered by operating cash flow (8.5%).
Interest Coverage: A50's interest payments on its debt are not well covered by EBIT (1.9x coverage).
Balance Sheet
Inventory Level: A50 has a high level of physical assets or inventory.
Debt Coverage by Assets: A50's debt is not covered by short term assets (assets are 0.5x debt).
Next Steps
Dividend
What is Thomson Medical Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate A50's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate A50's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if A50's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A50's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A50's dividend in 3 years as they are not forecast to pay a notable one for the SG market.
Next Steps
Management
What is the CEO of Thomson Medical Group's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
Thomson Medical Group has no CEO, or we have no data on them.
Management Age and Tenure
0.8yrs
Average Tenure
Experienced Management: A50's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
1.5yrs
Average Tenure
Experienced Board: A50's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Jimmy Wong (46yo)
Group Chief Financial Officer of TMC Life Sciences Berhad
- Tenure: 0yrs
Chee Kien Seah
Managing Director of RSP Architecture & Design
- Tenure: 0yrs
Swee Chiew Beh
Managing Director of RSP Civil & Structural Engineering
- Tenure: 0yrs
Wan Binti Wan Mohd Abdullah Yaakob (34yo)
Group CEO of TMC Life Sciences Berhad & CEO of Thomson Hospital Kota Damansara
- Tenure: 0yrs
Zing Tan
Chief Risk Officer & Director of Group Finance
- Tenure: 0.6yrs
Foo Soon Soo
Joint Secretary
- Tenure: 1.1yrs
Lim Hoi Leong
Joint Secretary
- Tenure: 1.1yrs
Teo Yann
Managing Director of Squire Mech Mechanical & Electrical Engineering
- Tenure: 0yrs
Wilson Sam
Executive Director & Group CFO
- Tenure: 0.6yrs
Board Members
Ser Miang Ng (69yo)
Non-Executive Independent Chairman
- Tenure: 3.8yrs
Pang Ong (59yo)
Independent Director
- Tenure: 3.8yrs
Roy Quek
Non-Executive Non-Independent Director
- Tenure: 1.5yrs
Freddie Heng
Non-Executive Non-Independent Director
- Tenure: 1.5yrs
Wilson Sam
Executive Director & Group CFO
- Tenure: 0.6yrs
Wee Lim
Non-Executive & Non-Independent Director
- Tenure: 0.6yrs
Lee Lam
Independent Non-Executive Director
- Tenure: 0.4yrs
Company Information
Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Thomson Medical Group Limited
- Ticker: A50
- Exchange: SGX
- Founded: 1979
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: S$1.507b
- Shares outstanding: 26.44b
- Website: https://www.thomsonmedicalgroup.com
Number of Employees
Location
- Thomson Medical Group Limited
- 101 Thomson Road, No. 20-04/05
- United Square
- Singapore
- 307591
- Singapore
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| A50 | SGX (Singapore Exchange) | Yes | Ordinary Shares | SG | SGD | Apr 2018 |
| 3H5 | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Apr 2018 |
Biography
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. Th ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/14 12:55 |
| End of Day Share Price | 2019/10/14 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.